Summary
- Current Price
- As of today, OGN price is $13.70, down -0.15% on
- Current Price All-Time High
- OGN price is currently -65.29% below its historical high of $39.48 set on
- Market Cap
- OGN current market cap is $4B, up +47.38% over the past 365 days
- PE Ratio
- OGN current PE ratio is 17.55
- Revenue
- OGN current annual revenue is $6.22B, down -2.92% year-over-year
- Next Earnings
- The next earnings release for OGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Organon & Co. |
| Ticker | NYSE: OGN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | organon.com |
| Employees | 10,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $13.70 | |
| Price, 1D Change | -0.15% | |
| $4B | ||
| 0.58% | ||
| 17.55 | ||
| 0.71 | ||
| $6.22B | ||
| Revenue, 1Y Change | -2.92% | |
| $0.72 | ||
| EPS, 1Y Change | -78.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.02 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OGN.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.72 | ||
| EPS Estimate | $3.62 | N/A |
| EPS Est. Change | +404.95% | N/A |
| $6.22B | ||
| Revenue Estimate | $6.13B | N/A |
| Revenue Est. Change | -1.46% | N/A |
| Current Price | $13.70 | |
| Price Target | $11.50 | - |
| Price Tgt. Change | -16.06% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.11 | $3.33 | -18.86% | |
| $3.76 | $0.72 | -80.95% | |
| $3.62 | N/A | +404.95% | |
| $3.64 | N/A | +407.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.41B | $6.40B | -0.06% | |
| $6.23B | $6.22B | -0.19% | |
| $6.13B | N/A | -1.46% | |
| $6.24B | N/A | +0.32% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $13.70 | |
| $9.78 | ||
| $13.51 | ||
| $11.26 | ||
| $13.27 | ||
| $0.07 | ||
| 0.71 | ||
| $0.05 | ||
| 72.24 | ||
| 3.23% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.02 | |
| Upcoming | N/A | N/A |
| 2.48% | ||
| Total Dividend | $0.34 | |
| $88.00M | ||
| 47.06% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $6.22B | ||
| $0.72 | ||
| $3.31B | ||
| 53.30% | ||
| $1.22B | ||
| 19.63% | ||
| $187.00M | ||
| 3.01% | ||
| $1.57B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 11.70 | ||
| 1.82 | ||
| 1.23 | ||
| - | ||
| 6 | ||
| 1.28 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 17.55 | ||
| 0.59 | ||
| 3.58 | ||
| 7.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $752.00M | ||
| $574.00M | ||
| $12.87B | ||
| $4.35B | ||
| $12.12B | ||
| $2.39B | ||
| $8.80B | ||
| $56.00M | ||
| $952.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $6.03B | ||
| $2.09B | ||
| $2.90B | ||
| $0.00 | ||
| $361.00M | ||
| $0.00 | ||
| $238.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $700.00M | ||
| -$390.00M | ||
| -$561.00M | ||
| $192.00M | ||
| $508.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BNP Paribas | → | |
| Piper Sandler | → | |
| Barclays | → | |
| Barclays | ||
| Morgan Stanley | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
No data
Screeners with OGN
FAQ
- What is the ticker symbol for Organon & Co.?
- The ticker symbol for Organon & Co. is NYSE:OGN
- Does Organon & Co. pay dividends?
- Yes, Organon & Co. pays dividends. The last payment was $0.02, with an ex-dividend date on August 14, 2026
- What sector is Organon & Co. in?
- Organon & Co. is in the Healthcare sector
- What industry is Organon & Co. in?
- Organon & Co. is in the General Drug Manufacturers industry
- What country is Organon & Co. based in?
- Organon & Co. is headquartered in United States
- When did Organon & Co. go public?
- Organon & Co. initial public offering (IPO) was on May 14, 2021
- Is Organon & Co. in the S&P 500?
- No, Organon & Co. is not included in the S&P 500 index
- Is Organon & Co. in the NASDAQ 100?
- No, Organon & Co. is not included in the NASDAQ 100 index
- Is Organon & Co. in the Dow Jones?
- No, Organon & Co. is not included in the Dow Jones index
- When was Organon & Co. last earnings report?
- Organon & Co.'s most recent earnings report was on July 31, 2026
- When does Organon & Co. report earnings?
- The next expected earnings date for Organon & Co. is November 9, 2026
Data Sources & References
- OGN Official Website www.organon.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821825/000110465926013888/0001104659-26-013888-index.htm
- OGN Profile on Yahoo Finance finance.yahoo.com/quote/OGN
- OGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ogn
